Jilin Province Huinan Changlong Bio-pharmacy Company Limited

SEHK:8049 Stock Report

Market Cap: HK$773.1m

Jilin Province Huinan Changlong Bio-pharmacy Balance Sheet Health

Financial Health criteria checks 5/6

Jilin Province Huinan Changlong Bio-pharmacy has a total shareholder equity of CN¥1.6B and total debt of CN¥83.8M, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are CN¥2.4B and CN¥780.2M respectively. Jilin Province Huinan Changlong Bio-pharmacy's EBIT is CN¥181.3M making its interest coverage ratio -5.4. It has cash and short-term investments of CN¥645.7M.

Key information

5.3%

Debt to equity ratio

CN¥83.75m

Debt

Interest coverage ratio-5.4x
CashCN¥645.68m
EquityCN¥1.58b
Total liabilitiesCN¥780.16m
Total assetsCN¥2.36b

Recent financial health updates

No updates

Recent updates

Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

May 21
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

Apr 04
There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Mar 26
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

Dec 27
Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Jul 12
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

Jun 05
It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Nov 26
How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Financial Position Analysis

Short Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥666.9M).

Long Term Liabilities: 8049's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥113.2M).


Debt to Equity History and Analysis

Debt Level: 8049 has more cash than its total debt.

Reducing Debt: 8049's debt to equity ratio has increased from 0.2% to 5.3% over the past 5 years.

Debt Coverage: 8049's debt is well covered by operating cash flow (377.3%).

Interest Coverage: 8049 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies